Kolexia
Bourliere Marc
Gastro-entérologie
Hopital Saint Joseph
Marseille, France
357 Activités
782 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hépatite Hépatite C Hépatite C chronique Cirrhose du foie Fibrose Hépatite chronique Carcinome hépatocellulaire Hépatite A Tumeurs du foie

Industries

Gilead
37 collaboration(s)
Dernière en 2023
Abbvie
30 collaboration(s)
Dernière en 2023
Roche
4 collaboration(s)
Dernière en 2022
Tillotts
3 collaboration(s)
Dernière en 2022

Dernières activités

Real-world economic burden of hepatitis C and impact of direct-acting antivirals in France: A nationwide claims data analysis.
Liver international : official journal of the International Association for the Study of the Liver   20 février 2024
NATiV3: A Randomised, Double-blind, Placebo-controlled, Multicentre, Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With Non-cirrhotic Non-alcoholic Steatohepatitis (NASH) and Fibrosis Stages F2 and F3
Essai Clinique (Inventiva Pharma)   24 janvier 2024
SCREANIT: SCREaning of Advanced Liver Fibrosis Using Non-Invasive Tests in General Population
Essai Clinique (CHU Angers)   08 janvier 2024
Hepatitis C virus cure from direct-acting antivirals and mortality: Are people with and without a history of injection drug use in the same boat? (ANRS CO22 Hepather cohort).
Drug and alcohol review   22 décembre 2023
Management of chronic HBV-HDV patients chronic HBV-HDV infection: A review on new management options.
United European gastroenterology journal   02 décembre 2023
International survey among hepatologists and pulmonologists on the hepatic hydrothorax: plea for recommendations.
BMC gastroenterology   12 septembre 2023
Impaired health-related quality of life in the HCV cure era: who is concerned? (ANRS CO22 HEPATHER French cohort).
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation   16 août 2023
CO13Hepavih: Inter Cohorts and Clinical Centres Collaborations of Subjects Co-infected With Hepatitis C and Human Immunodeficiency Virus (Collaboration Inter Cohortes et Centres Cliniques de Sujets Co-infectés Par Les Virus de l'immunodéficence Humaine et de l'hépatite C)
Essai Clinique (Merck-Serono)   01 août 2023
Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma: Real-life Data on Liver Disease, Treatment and Prognosis.
Journal of clinical and translational hepatology   16 mai 2023
Bulevirtide monotherapy is safe and well tolerated in patients with chronic hepatitis D (CHD): An integrated safety analysis of 48-week data
Abstracts of the 55th A.I.S.F. - Italian Association for the Study of the Liver - Annual Meeting 2023   01 mars 2023